Redbiotec AG

Redbiotec AG focuses on the generation of vaccine products to prevent Herpesvirus infections and on an oncology program using microorganisms for cancer treatment. Redbiotec AG was founded in 2006 as spin-off from the ETH Zürich and is located in the BIO-TECHNOPARK Schlieren-Zürich in Switzerland. For more information please visit www.redbiotec.ch.
 

Details


Address:
Redbiotec AG

Wagistrasse 23
-
8952 Schlieren
Switzerland
Field of Activity:
Research & Development
Expansion:
international
Website:
Number of employess:
11-50
Founding year:
2006